The journal einstein (São Paulo) – e-ISSN 2317-6385 is dedicated to dissemination of high-quality scientific content that advances our understanding of human disease with the goal of improving prevention, care, diagnostics and treatment of patients globally.
This article addresses some current issues about genetic polymorphisms studied in the non-small-cell lung cancer translational field. Furthermore, it discusses about new potential biomarkers regarding lung cancer risk and prognosis.
Genetic polymorphisms and non-small-cell lung cancer: future paradigms
MelloRAB. Genetic polymorphisms and non-small-cell lung cancer: future paradigms. Einstein (Sao Paulo). 2014;12(4):524-6. https://doi.org/10.1590/S1679-45082014RB2906
Mello,Ramon Andrade Bezerra de. Genetic polymorphisms and non-small-cell lung cancer: future paradigms. Einstein (Sao Paulo)., v. 12, n. 4, p. 524-526, Nov. 2014. https://doi.org/10.1590/S1679-45082014RB2906
Mello,R.A.B. (2014). Genetic polymorphisms and non-small-cell lung cancer: future paradigms. Einstein (Sao Paulo).,12(4), 524-526. https://doi.org/10.1590/S1679-45082014RB2906
Mello,Ramon Andrade Bezerra de. Genetic polymorphisms and non-small-cell lung cancer: future paradigms. Einstein (Sao Paulo). [online]. 2014, vol. 12, n. 4, [cited 2025-09-06], pp.524-526. Available from: <https://journal.einstein.br/article/genetic-polymorphisms-and-non-small-cell-lung-cancer-future-paradigms/>. ISSN 1679-4508. https://doi.org/10.1590/S1679-45082014RB2906
Figure 5
Risk of bias assessment of non-RCTs using the ROBINS-I tool
Non-RCT, nonrandomized controlled trial; ROBINS-I, Risk of Bias in Non-Randomized Studies-of Interventions